Editorial Article
How data and AI are accelerating cancer clinical trials
Phesi founder, Dr. Gen Li, shares how patient-centric data science and AI are set to transform global healthcare outcomes in cancer
Through extensive research, experimentation, and clinical trials, experts in the field of drug discovery and development identify promising biopharmaceutical or pharmaceutical drug candidates, optimize their efficacy and safety profiles, and navigate regulatory processes for eventual market approval. From innovative therapies to groundbreaking treatments, this dynamic scientific field plays a pivotal role in revolutionizing medicine and saving lives.
Phesi founder, Dr. Gen Li, shares how patient-centric data science and AI are set to transform global healthcare outcomes in cancer